Cronos Group PE Ratio 2017-2019 | CRON
Current and historical p/e ratio for Cronos Group (CRON) from 2017 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cronos Group PE ratio as of July 19, 2019 is 53.46.
|Cronos Group PE Ratio Historical Data
||TTM Net EPS
||Finance - Investment Management
Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.